DA-2811

DA-2811 · Dong-A ST Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DA-2811, covering 2025-03-14 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 2]

See pricing